Read More Pharma Industry News Incyte breaks new ground in EU cancer care with first PD‑1 drug for tough gastrointestinal tumors Discover how Incyte’s EU backing for its MacroGenics‑partnered cancer drug Zynyz could shift immunotherapy competition in gastrointestinal cancers. byPallavi MadhirajuJanuary 31, 2026